Drugs / DMPA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT03255941 Comparator | Mar → Jul 2018 | — | FHI 360 | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DMPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03255941 ↗ |
| Route | Intramuscular | “These first time users will also be randomly assigned to receive intramuscular or subcutaneous injections of DMPA.” NCT03255941 ↗ |
| Route | Subcutaneous | “These first time users will also be randomly assigned to receive intramuscular or subcutaneous injections of DMPA.” NCT03255941 ↗ |